Snapshot from Jun 26, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / People / Douglas Mack
Person

Douglas Mack

Tracked across 1 events · 6 articles · First seen Jun 02, 2026 · Last active Jun 03, 2026

Sentiment
20
Attention
3
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
3 20
Tech
DBV Technologies screens first THRIVE participant
DBV Technologies announced the screening of the first participant in its THRIVE Phase 2 clinical study for the VIASKIN Peanut Patch. This study evaluates the efficacy and safety of the patch in infants aged 6…
Impact: Douglas Mack, an Assistant Clinical Professor at McMaster University, screened the first participant in the THRIVE study and is a principal investigator, contributing his expertise to the research.
Jun 02, 2026 · 6 articles
Key Actions (1)
70 Douglas Mack screened participantDBV Technologies screens...
NEWSDESK
Track Douglas Mack live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.